which is required for its activity, and also indirectly through the activation of Akt (also called PKB) [12] . Lithium has been shown to protect primary neural cultures from several cell death stimuli via GSK-3 inhibition [13] . On the other hand, GSK-3 inhibition by lithium also induces morphological differentiation in the mouse neuroblastoma cell line, Neuro 2a [14] . Although it is effective in clinical studies, this drug is not a selective GSK-3 inhibitor. Lithium affects more than one target in apoptotic proteins such as Bcl-2, p53, protein kinase C and others [15] [16] [17] [18] . Moreover [17, 18] . [19] [20] [21] [22] [23] [24] . [22] [23] [24] [25] [26] [27] [28] [29, 30] [31] [32] [33] [34] [35] [36] [37] . Sirtuins (Fig. 3) . In order to clarify the pathway implicated in the 
Recent studies have indicated that GSK-3 inhibitors may have a potential application in cancer treatments specifically ovarian cancer, hepatocellular carcinoma and other tumours

Thus, GSK-3 inhibitors inhibited cell growth in colorectal cancer cells and myeloma cells. Accordingly, it is important to gain a better understanding of the mechanisms involved in GSK-3 inhibition-induced cell cycle arrest for pharmacological treatment of cancer and also human gliomas
. Likewise, GSK-3 is implicated in the control of the Wnt/␤-catenin pathway and thus in the regulation of proliferation and GSK-3 inhibitors may have pro-carcinogenic properties. Nowadays, it is well known that in all eukaryotic cells, regulation of cell cycle progression is driven by sequential activation of a group of serine-threonine kinases called cyclin-dependent kinases (Cdks) and their partners, cyclins. Cdks in association with their activating subunits: cyclin D-cdk4/6 and cyclin E-cdk2 complexes regulate G1/S progression, cyclin A-cdk2 complexes mediate S/G2 transitions, and cyclin B-cdc2 complexes mediate M-phase progression
. In addition to cyclins, sirtuin 2 (SIRT2) may regulate cell proliferation through the mitotic exit. SIRT2 belongs to the family of histone-deacetylases (HDAC), considered as epigenetic factors controlling the activity of several genes
000). After 12 hrs of incubation, blots were washed thoroughly in TBS-T buffer and incubated for 1 hr with a peroxidase-conjugated IgG secondary antibody (1:3000). Immunoreactive protein was visualized using a chemiluminescence-based detection kit. Protein load was monitored using phenol red staining of the blot membrane or immunodetection of actin-beta.
Reverse transcriptase-PCR
Results
Expression of GSK-3 in B65 neuroblastoma cell line
Levels of GSK-3, and specifically its inactive form pGSK-3 Ser9, were evaluated in B65 cells by Western blot analysis at the concentration of Li
E.M. of four or five separate experiments with four or five different culture preparations (n ϭ 4-5). (B) Evaluation of anti-apoptotic effects of zVAD-fmk on SB-415286 20 M. The percentage of nuclei with subdiploid peak (apoptotic peak) was about 30% for SB-415286 at 24 hrs of treatment and zVAD-fmk did not prevent apoptosis. Statistical significance was determined by one-way ANOVA followed by Tukey's tests: *P Ͻ 0.05 versus control.
Fig. 5 Immunoblots showing the expression of AIF in B65 neuroblastoma cells treated with Li ϩ 10 mM and SB-415286 30 M, for 24 hrs.
The band intensities levels were calculated as percentages of the control values, which were normalized to ␤-actin. Bars represent means Ϯ S.E.M. of four or five separate experiments with four or five different culture preparations (n ϭ 4-5). The statistical analysis was carried out with the one-way ANOVA followed by Tukey's test. cellular model, GSK-3 is present and lithium exerts its effects by phosphorylation mechanisms.
Effects of lithium and SB-415286 on B65 cell proliferation and apoptosis
To assess whether GSK-3 inhibition affects the proliferation of B65 neuroblastoma cells, we examined the effects of different concentrations of GSK-3 inhibitors using the MTT method (Fig. 2). Cells were treated with increasing concentrations of
apoptotic death of B65 cells, we determined the enzymatic activity of caspase 3, and while SB-415286 induced a significant increase, Li
ϩ had no effect (Fig. 4) . Furthermore, a pan inhibitor of caspases such as zVAD-fmk did not block the apoptosis induced by SB-415286 (Fig. 4) (Fig. 6 ). (Fig. 9) . By contrast, significant up-regulation of cyclin D and cyclin E transcriptional activity was observed.
Effects of lithium and SB-415286 on cell cycle
Effects of lithium and SB-415286 on the expression of cell cycle proteins in B65 neuroblastoma cells
Changes in the expression of SIRT2 after treatment with GSK-3 inhibitors
Although SB-415286 and Li ϩ showed selective G2/M inhibition mediated by Cdc2, we studied an additional mechanism involved in cell cycle arrest that is regulated by Cdc2, namely SIRT2. Expression of SIRT2 significantly increased after treatment with SB-415286, while lithium had no effect (Fig. 10) . Furthermore, gene expression analysis showed a similar pattern (Fig. 9) . [10, 36, [38] [39] [40] . However, previous studies demonstrated a dual role of lithium in cell proliferation, inhibiting or increasing cell growth depending on cellular type [19, 20] implicated SIRT2 in the control of the cell cycle [32] [33] [34] [35] . Furthermore, in different cell models, SIRT2 reduces cellular proliferation, while SIRT2 expression is down-regulated in human gliomas [32, 33] . Likewise, drugs that induce microtubule alteration such as nocodazole inhibited cell cycle progression in mitosis by SIRT2 activation [35, [42] [43] [44] [48] [49] [50] . In Alzheimer's disease cdc2 could be activated in neurons and human brain and cyclin B-Cdc2 might be involved in the hyperphosphorylation of tau and also in the regulation of neuronal apoptosis [51, 52] . Furthermore, in cultures of cerebellar granule cells, activation of cdc2 by the apoptotic stimuli of serum and potassium withdrawal connects re-entry in the cell cycle with mitochondrial apoptosis activation through bad phosphorylation [53, 54] . In summary, the results of the present study provide evidence that GSK-3 inhibitors induce G2/M arrest in rat B65 neuroblastoma cells through regulation of Cdc2 activity, specifically the phosphorylation of Cdc2 and thus inhibition of this enzyme. 
